148 related articles for article (PubMed ID: 15516975)
1. Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line.
Schlosser I; Hölzel M; Hoffmann R; Burtscher H; Kohlhuber F; Schuhmacher M; Chapman R; Weidle UH; Eick D
Oncogene; 2005 Jan; 24(3):520-4. PubMed ID: 15516975
[TBL] [Abstract][Full Text] [Related]
2. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
Marcotte R; Chen JM; Huard S; Wang E
J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
[TBL] [Abstract][Full Text] [Related]
3. Role of myc amplification and overexpression in cell growth, differentiation and death.
Koskinen PJ; Alitalo K
Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
5. Mnt takes control as key regulator of the myc/max/mxd network.
Wahlström T; Henriksson M
Adv Cancer Res; 2007; 97():61-80. PubMed ID: 17419941
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
7. Translocations involving c-myc and c-myc function.
Boxer LM; Dang CV
Oncogene; 2001 Sep; 20(40):5595-610. PubMed ID: 11607812
[TBL] [Abstract][Full Text] [Related]
8. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
Sallot M; Lascombe I; Bermont L; Jouvenot M
Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
[TBL] [Abstract][Full Text] [Related]
10. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation.
Lin CJ; Cencic R; Mills JR; Robert F; Pelletier J
Cancer Res; 2008 Jul; 68(13):5326-34. PubMed ID: 18593934
[TBL] [Abstract][Full Text] [Related]
11. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
12. The c-Myc target gene network.
Dang CV; O'Donnell KA; Zeller KI; Nguyen T; Osthus RC; Li F
Semin Cancer Biol; 2006 Aug; 16(4):253-64. PubMed ID: 16904903
[TBL] [Abstract][Full Text] [Related]
13. The role of c-myc in cellular growth control.
Schmidt EV
Oncogene; 1999 May; 18(19):2988-96. PubMed ID: 10378694
[TBL] [Abstract][Full Text] [Related]
14. c-MYC impairs immunogenicity of human B cells.
Schlee M; Schuhmacher M; Hölzel M; Laux G; Bornkamm GW
Adv Cancer Res; 2007; 97():167-88. PubMed ID: 17419945
[TBL] [Abstract][Full Text] [Related]
15. Nm23-M2/NDP kinase B induces endogenous c-myc and nm23-M1/NDP kinase A overexpression in BAF3 cells. Both NDP kinases protect the cells from oxidative stress-induced death.
Arnaud-Dabernat S; Masse K; Smani M; Peuchant E; Landry M; Bourbon PM; Le Floch R; Daniel JY; Larou M
Exp Cell Res; 2004 Dec; 301(2):293-304. PubMed ID: 15530864
[TBL] [Abstract][Full Text] [Related]
16. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation.
Mezquita P; Parghi SS; Brandvold KA; Ruddell A
Oncogene; 2005 Jan; 24(5):889-901. PubMed ID: 15580293
[TBL] [Abstract][Full Text] [Related]
17. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
[TBL] [Abstract][Full Text] [Related]
18. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
19. Control of cell proliferation by Myc family genes.
Eilers M
Mol Cells; 1999 Feb; 9(1):1-6. PubMed ID: 10102563
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
